Xenetic Biosciences (XBIO)
(Delayed Data from NSDQ)
$4.04 USD
+0.12 (2.97%)
Updated May 9, 2024 12:18 PM ET
After-Market: $3.85 -0.19 (-4.74%) 4:30 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.79 | 0.00% |
Earnings Summary
For their last quarter, Xenetic Biosciences (XBIO) reported earnings of -$0.77 per share, beating the Zacks Consensus Estimate of $-0.87 per share. This reflects a positive earnings surprise of 11.49%. Look out for XBIO's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.79 per share, reflecting a year-over-year decrease of 31.67%.
Earnings History
Price & Consensus
Zacks News for XBIO
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Lags Revenue Estimates
XBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services